Product Images Emtricitabine And Tenofovir Disoproxil Fumarate

This appears to be a label of a medication for a prescription drug called Tenofovir DisoproXil. The label provides information such as the dosage, NDC number, and the manufacturer's name and location. Additionally, the label advises to keep the medication out of reach of children and to dispense the medication guide provided separately to each patient.*

This is a description of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets. The package contains 30 tablets, each with 133 mg/200 mg of Emtricitabine and Tenofovir Disoproxil Fumarate respectively. The tablets are coated and are equivalent to 163 mg of Tenofovir Disoproxil. The recommended dosage is mentioned in the package insert. The tablets need to be stored at 20°C to 25°C and should be kept out of reach of children. The manufacturer is Cadia Healthcare Ltd. in Ahmedabad, India, and the distributor is Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

This is a description of medication - Emtricitabine and Tenofovir Disoproxil Fumarate Tablets. It contains 167 mg of emtricitabine and 250 mg of tenofovir disoproxil fumarate, which is equivalent to 204 mg of tenofovir disoproxil. It is used for HIV treatment. The usual dosage instructions are provided in the package insert. It should be stored at room temperature, and the container must be kept tightly closed. This package is child-resistant, and the medication guide must be provided to each patient. It is manufactured by Cadila Healthcare Limited in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

This is a medication package containing 30 film-coated tablets of Emtricitabine and Tenofovir Disoproxil Fumarate. The tablets contain 200mg of emtricitabine and 300mg of tenofovir disoproxil fumarate, equivalent to 245mg of tenofovir disoproxil. The package includes a medication guide that should be provided to each patient. The usual dosage is indicated in the package insert. The medication should be kept at temperatures between 20°C to 25°C and excursions up to 15°C to 30°C are acceptable. The package is child-resistant and should be kept out of children's reach. The manufacturer is Cadia Healthcare Ltd in Ahmedabad, India, and the medication is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*